Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
- Citation:
- J Clin Oncol vol 27 (11) 1800-1805
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 679
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA047577, CA33601, CA77597, CA11789, U10 CA077658, U10 CA031983, CA02599, CA47577, CA41287, CA03927, U10 CA031946, CA77651, U10 CA033601, U10 CA077597, P30 CA023108, U10 CA004326, U10 CA041287, U10 CA047559, U10 CA077651, CA04326, CA47559, CA47642, CA77658, U10 CA047642, CA31983, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Antonius A. Miller Daryl J. Murry Kouros Owzar Donna R. Hollis Erin B. Kennedy Ghassan Abou-Alfa Apurva Desai Jimmy Hwang Miguel A. Villalona-Calero E. Claire Dees Lionel D. Lewis Marwan G. Fakih Martin J. Edelman Fred Millard Richard C. Frank Raymond J. Hohl Mark J. Ratain
- Networks:
- Study
- CALGB-60301
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- Faze, Original Reports, Phase I and Clinical Pharmacology